Abstract
IntroductionThe sudden arrival of the COVID-19 pandemic placed significant stresses on supply chains including viral transport medium (VTM). The VTM that was urgently required needed to support viral replication, as well as other routine diagnostic approaches. We describe the preparation and validation testing of VTM for rapidly expanding diagnostic testing, where the capacity of the VTM to preserve viral integrity, for culture, isolation and full sequence analysis, was maintained.MethodsVTM was prepared using different methods of sterilization then ‘spiked’ with virus. The VTM was investigated using viral culture in Vero cells, and for nucleic acid detection by quantitative PCR.ResultsThe best results were obtained by filter and autoclave-based sterilization. The VTM proved robust for culture-based analyses provided the inoculated VTM was stored at 4 °C, and tested within 48 h. The filtered VTM also supported PCR-based diagnosis for at least 5 days when the mock inoculated VTM was held at room temperature.DiscussionThe manual handling of VTM production, including filling and sterilization, was optimized. SARS-CoV-2 was spiked into VTM to assess different sterilization methods and measure the effects of storage time and temperature upon VTM performance. While most diagnostic protocols will not require replication competent virus, the use of high quality VTM will allow for the next phase of laboratory analysis in the COVID-19 pandemic, including drug and antibody susceptibility analysis of re-isolated SARS-CoV-2, and for the testing of vaccine escape mutants.
Highlights
The sudden arrival of the COVID-19 pandemic placed significant stresses on supply chains including viral transport medium (VTM)
This paper examines the ability of viral transport medium to support COVID-19 viral culture
The antifungal activity of the VTM was decreased by autoclaving or gamma irradiation, whereas the antibacterial activity was not affected by the method of preparation
Summary
The sudden arrival of the COVID-19 pandemic placed significant stresses on supply chains including viral transport medium (VTM). We describe the preparation and validation testing of VTM for rapidly expanding diagnostic testing, where the capacity of the VTM to preserve viral integrity, for culture, isolation and full sequence analysis, was maintained. The COVID-19 global pandemic has tested the supply chains that support the diagnosis of infections, including testing equipment and assay components and the availability of swabs and viral transport medium (VTM), in some areas, became limiting for COVID-19 testing. The Media Production Unit (MPU) at the Peter Doherty Institute for Infection and Immunity, a small accredited (ISO/IEC17025:2017), near at-cost, media provider for local and regional diagnostic laboratories using largely manual processes, was asked to supply VTM at 20,000 units per week. This study analyses sterilization and VTM ability to support to the growth of SARS-CoV-2 in permissive cells
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have